Establishing a filarial clinical research platform in a resource-limited setting: Lessons and experiences from Tanzania
PLOS Neglected Tropical Diseases · 2026
DOI: 10.1371/journal.pntd.0013983 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von Ndekya M Oriyo und 31 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Medical Research, Dar es Salaam, Tanzania. Hauptthemen laut MEDLINE: Elephantiasis, Filarial, Biomedical Research. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Forschung, Technologie und Raumfahrt.
Abstract (Originalsprache)
This paper examines the establishment and lessons learned from the LeDoxy Trial, a multinational, double-blind, randomized, placebo-controlled study that evaluated doxycycline (200 mg/d and 100 mg/d) over six weeks for the treatment of filarial lymphedema in Tanzania’s Lindi and Pwani regions. Conducted from 2018 to 2021 across four sites, the trial enrolled 420 participants aged 14–65 years, addressing a critical gap in lymphatic filariasis (LF) research in geographically remote and historically under-researched areas. The trial faced significant challenges, including limited pre-existing research infrastructure, community research fatigue, and disruptions from the COVID-19 pandemic, which delayed regulatory approvals and supply chains. To overcome these, the TAKeOFF Consortium with Tanzania’s National Institute for Medical Research (NIMR) as local sponsor led a 12-month site preparation effort, upgrading Lindi’s laboratory from a 2-star to a 4-star rating through infrastructure enhancements (e.g., centrifuges, freezers) and staff training in Good Clinical Laboratory Practice (GCLP). Community health workers (CHWs) leveraging established community-directed approaches from NTD control programs played a pivotal role, achieving a 92% retention rate through targeted recruitment, door-to-door engagement, and follow-up support, including the distribution of hygiene kits. The trial trained 93 healthcare professionals in LF management and clinical research, fostering a research culture despite initial resistance. Additional strategies included remote monitoring to adapt to travel restrictions and stakeholder collaboration to address cultural misconceptions, such as stigma around LF. These efforts not only ensured trial success but also created foundational capacity that has begun to support post-trial research activities, with ongoing evaluation needed to assess long-term sustainability. This paper provides comprehensive, integrated documentation of the infrastructure development process from laboratory accreditation and regulatory navigation to community engagement and sustainability planning, offering actionable guidance for conducting high-quality NTD trials in resource-limited settings. The lessons emphasizing local sponsorship, adaptive protocols, and community trust demonstrate how strategic investments in research infrastructure, local capacity-building, and stakeholder engagement can strengthen clinical research ecosystems in LMICs, advancing health systems, local ownership, and global health equity. This paper focuses exclusively on the operational and implementation aspects of establishing the trial infrastructure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- National Institute for Medical Research, Dar es Salaam, Tanzania.
- Kilimanjaro Clinical Research Institute, Moshi, Tanzania.
- National Institute for Medical Research (NIMR), Mbeya Medical Research Centre, Mbeya, Tanzania.
- Division of Infectious Diseases and Tropical Medicine, University Hospital Munich, Ludwig-Maximilians-University (LMU), Munich, Germany.
- Sokoine Regional Referral Hospital, Lindi, Tanzania.
- Mbanja Dispensary, Lindi, Tanzania.
ORCID-Profile: Ndekya M Oriyo
Förderung
- Bundesministerium für Forschung, Technologie und Raumfahrt
Zitieren
APA
Oriyo, N. M., Munga, M. A., Ngenya, A., Ogondiek, J., Mandara, W., Shirima, W., Akyoo, J., Laizer, R., Kamugisha, M., Kapera, H., Ngwatu, R., Sanga, G., Mhidze, J., Haule, A., Feichtner, A., Mposheleye, H., Mwanga, F. A., Chinguile, H. A., Makalla, A. J., …, & Mwingira, U. (2026). Establishing a filarial clinical research platform in a resource-limited setting: Lessons and experiences from Tanzania. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013983
Vancouver
Oriyo NM, Munga MA, Ngenya A, Ogondiek J, Mandara W, Shirima W, et al. Establishing a filarial clinical research platform in a resource-limited setting: Lessons and experiences from Tanzania. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0013983
BibTeX
@article{Oriyo2026,
author = {Oriyo, Ndekya M and Munga, Michael A and Ngenya, Abdallah and Ogondiek, John and Mandara, Wilfred and Shirima, Winfrida and Akyoo, Jonathan and Laizer, Ruth and Kamugisha, Mathias and Kapera, Hanifa and Ngwatu, Rafikieli and Sanga, Gracia and Mhidze, Jacklina and Haule, Antelmo and Feichtner, Anja and Mposheleye, Haile and Mwanga, Farida A and Chinguile, Hatima A and Makalla, Alexander J and Mabenga, Peter and Demetrius, Max and Mosoba, Maureen M and Moshi, Dennis and Mgaya, Yusuph and Debrah, Linda Batsa and Kroidl, Inge and Klarmann-Schulz, Ute and Wanji, Samuel and Debrah, Alexander Yaw and Hoerauf, Achim and Kalinga, Akili and Mwingira, Upendo},
title = {Establishing a filarial clinical research platform in a resource-limited setting: Lessons and experiences from Tanzania},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
doi = {10.1371/journal.pntd.0013983}
}
EUVIMED